Charming Medical Limited (MCTA)
Nov 9, 2026 - MCTA was suspended pending delisting
29.36
+1.86 (6.75%)
Inactive Ā· Last trade price on Nov 11, 2025
Charming Medical Revenue
In the fiscal year ending March 31, 2026, Charming Medical had annual revenue of $4.81M, down -22.73%. Charming Medical had revenue of $2.65M in the half year ending March 31, 2026, a decrease of -21.52%.
Revenue (ttm)
$4.81M
Revenue Growth
-22.73%
P/S Ratio
104.89
Revenue / Employee
$165,783
Employees
29
Market Cap
504.26M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.81M | -1.41M | -22.73% |
| Mar 31, 2025 | 6.22M | 206.38K | 3.43% |
| Mar 31, 2024 | 6.02M | 2.48M | 70.37% |
| Mar 31, 2023 | 3.53M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
MCTA News
- 10 days ago - Charming Medical Nasdaq trading to be suspended after delisting determination - TheFly
- 11 days ago - Charming Medical Limited Announces Nasdaq Delisting Determination and Suspension of Trading - GlobeNewsWire
- 15 days ago - Charming Medical Limited Announces Receipt of Nasdaq Delisting Determination Notice. - GlobeNewsWire
- 21 days ago - Charming Medical Limited Notified of Anticipated Delisting fromĀ TheĀ Nasdaq Stock Market - GlobeNewsWire
- 3 months ago - Charming Medical Annual report: Q4 2026 - Filings
- 9 months ago - Investors who lost money with Charming Medical Limited (NASDAQ: MCTA) should contact the Shareholders Foundation in connection with Lawsuit - PRNewsWire
- 11 months ago - Nasdaq halts Charming Medical - TheFly
- 1 year ago - SEC orders trading in Charming Medical securities be suspended - TheFly